© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
May 14, 2020
The impact of COVID-19 on the health plan enterprise appears to be practical and functional rather than strategic and financial.
February 11, 2019
The economics of one and done gene therapies dictate a revenue model that requires outcomes-based risk.
May 15, 2018
Oncology economics is the product of driving forces in the health insurance market that are intrinsic to oncology in managed care and unlikely to change.